The University of Southampton
University of Southampton Institutional Repository

Government subsidies and policies for mask production under COVID-19: is it wise to control less?

Government subsidies and policies for mask production under COVID-19: is it wise to control less?
Government subsidies and policies for mask production under COVID-19: is it wise to control less?

Under the COVID-19 pandemic, governments worldwide have subsidized manufacturers or consumers on the production or purchase of masks. However, the impacts of these subsidies on the mask supply chain (MSC) operations are unclear. Motivated by our interview with a mask manufacturer as well as the observed real-world practices, we establish consumer utility-based stylized models to analytically examine government subsidies and policies in the MSC. We utilize the infection transmission model to capture the social health risk during the COVID-19 outbreak. The government aims to maximize social welfare, which includes the manufacturer's profit, consumer surplus, social health risk, and government subsidy expenditure. Results indicate that when the price is not controlled (i.e., the manufacturer decides it), the manufacturer and consumer subsidy programs are equally efficient in enhancing consumer surplus as well as reducing harm to social health risk under COVID-19. Thus, the government can conduct a subsidy scheme that is easier to implement in practice. However, we surprisingly find that the government's excessive intervention will cause disequilibrium in the MSC. When the price or the manufacturer's dishonest behavior is fully controlled by the government, subsidizing the MSC is not always advisable. Besides, our findings are consistent with the public interest theory; that is, the proper implementation of dishonesty prevention and pricing control policies can improve social welfare but sacrifice consumer surplus. Our results contribute to healthcare operations management and generate managerial insights for MSC management during COVID-19 with industrial validation.

Blockchain, COVID-19, government subsidy, healthcare, mask supply chain (MSC), pricing control
0018-9391
3172-3188
Xu, Xiaoyan
98b815b6-5ac4-42cf-8429-da5cb889ab8c
Choi, Tsan Ming
594d42c1-0264-4e78-afc3-aa6076284cf4
Chung, Sai Ho
70dcb405-2750-4d44-a6b8-49b4c9a6d523
Shen, Bin
1b5a835f-00aa-4891-b77f-ada750a8fec2
Xu, Xiaoyan
98b815b6-5ac4-42cf-8429-da5cb889ab8c
Choi, Tsan Ming
594d42c1-0264-4e78-afc3-aa6076284cf4
Chung, Sai Ho
70dcb405-2750-4d44-a6b8-49b4c9a6d523
Shen, Bin
1b5a835f-00aa-4891-b77f-ada750a8fec2

Xu, Xiaoyan, Choi, Tsan Ming, Chung, Sai Ho and Shen, Bin (2022) Government subsidies and policies for mask production under COVID-19: is it wise to control less? IEEE Transactions on Engineering Management, 71, 3172-3188. (doi:10.1109/TEM.2022.3198101).

Record type: Article

Abstract

Under the COVID-19 pandemic, governments worldwide have subsidized manufacturers or consumers on the production or purchase of masks. However, the impacts of these subsidies on the mask supply chain (MSC) operations are unclear. Motivated by our interview with a mask manufacturer as well as the observed real-world practices, we establish consumer utility-based stylized models to analytically examine government subsidies and policies in the MSC. We utilize the infection transmission model to capture the social health risk during the COVID-19 outbreak. The government aims to maximize social welfare, which includes the manufacturer's profit, consumer surplus, social health risk, and government subsidy expenditure. Results indicate that when the price is not controlled (i.e., the manufacturer decides it), the manufacturer and consumer subsidy programs are equally efficient in enhancing consumer surplus as well as reducing harm to social health risk under COVID-19. Thus, the government can conduct a subsidy scheme that is easier to implement in practice. However, we surprisingly find that the government's excessive intervention will cause disequilibrium in the MSC. When the price or the manufacturer's dishonest behavior is fully controlled by the government, subsidizing the MSC is not always advisable. Besides, our findings are consistent with the public interest theory; that is, the proper implementation of dishonesty prevention and pricing control policies can improve social welfare but sacrifice consumer surplus. Our results contribute to healthcare operations management and generate managerial insights for MSC management during COVID-19 with industrial validation.

This record has no associated files available for download.

More information

Published date: 27 September 2022
Additional Information: Funding Information: The work of Bin Shen was supported by the National Natural Science Foundation of China under Grant 72271050 and Grant 71871051.
Keywords: Blockchain, COVID-19, government subsidy, healthcare, mask supply chain (MSC), pricing control

Identifiers

Local EPrints ID: 487202
URI: http://eprints.soton.ac.uk/id/eprint/487202
ISSN: 0018-9391
PURE UUID: e1933b27-fa7f-4fff-b7ef-f989da415284
ORCID for Xiaoyan Xu: ORCID iD orcid.org/0000-0003-4565-5986

Catalogue record

Date deposited: 16 Feb 2024 10:30
Last modified: 12 Oct 2024 03:01

Export record

Altmetrics

Contributors

Author: Xiaoyan Xu ORCID iD
Author: Tsan Ming Choi
Author: Sai Ho Chung
Author: Bin Shen

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×